There is a treatment available for people with my condition. It was fast-tracked by the Food and Drug Administration (FDA) in America and has been available there since Summer 2023. The UK medicines regulator (MHRA) approved Omaveloxolone (Skyclarys) in April 2025. It remains unavailable to NHS users in the UK. But why?
Subscribe to get access
Read more of this content when you subscribe today.
World According to Me: 